Psychedelic treatments have been considered in the treatment of mental health since the 1950s, following Albert Hofmann’s development of lysergic acid diethylamide (LSD-25) in 1938. Government ...

a non-hallucinogenic derivative of lysergic acid diethylamide (“LSD”), announced that the USPTO has granted the BETR-001 composition of matter patent US publication number US2023/0219955 with ...

While on CNN‘s “New Year’s Eve Live With Andy Cohen & Anderson Cooper” on Tuesday the electronic dancehall artist admitted he was currently on lysergic acid diethylamide, aka LSD ...